Rapid deracemization through solvent cycling: proof-of-concept using a racemizable conglomerate clopidogrel precursor

Area of Science:

• Chemical Engineering
• Crystallization Science
• Pharmaceutical Chemistry

Background:

• Clopidogrel is an important antiplatelet medication.
• Racemic mixtures of clopidogrel precursors pose challenges in chiral separation.
• Efficient deracemization is crucial for pharmaceutical synthesis.

Purpose of the Study:

• To develop a novel method for deracemizing conglomerate-forming clopidogrel precursors.
• To optimize conditions for rapid and efficient chiral separation.
• To demonstrate the utility of a repurposed Soxhlet apparatus for autonomous solvent manipulation.

Main Methods:

• Solution phase racemization of a clopidogrel precursor.
• Cyclic solvent removal and re-addition technique.
• Utilizing a modified Soxhlet apparatus for autonomous solvent control.
• Investigating the impact of crystal growth and dissolution rates on deracemization efficiency.

Main Results:

• Achieved rapid deracemization of the clopidogrel precursor.
• Identified optimal conditions: slow crystal growth coupled with fast dissolution.
• Demonstrated autonomous and efficient solvent cycling using a repurposed Soxhlet apparatus.
• Successfully separated enantiomers from a conglomerate mixture.

Conclusions:

• Cyclic solvent manipulation is an effective strategy for deracemizing conglomerate-forming compounds.
• The repurposed Soxhlet apparatus provides a robust platform for autonomous chiral separations.
• This method offers a promising approach for the efficient synthesis of enantiomerically pure pharmaceutical intermediates.